Literature DB >> 27471182

Health Care Infrastructure for Financially Sustainable Clinical Genomics.

Jochen K Lennerz1, Heather M McLaughlin2, Jason M Baron3, David Rasmussen3, Meini Sumbada Shin2, Nancy Berners-Lee4, Julie Miller Batten3, Kathryn J Swoboda5, Manish K Gala6, Harland S Winter7, Jeremy D Schmahmann8, David A Sweetser9, Marianne Boswell3, Maciej Pacula3, Albrecht Stenzinger10, Long P Le3, William Hynes3, Heidi L Rehm2, Anne Klibanski11, Stephen W Black-Schaffer3, Jeffrey A Golden12, David N Louis3, Scott T Weiss2, A John Iafrate3.   

Abstract

Next-generation sequencing has evolved technically and economically into the method of choice for interrogating the genome in cancer and inherited disorders. The introduction of procedural code sets for whole-exome and genome sequencing is a milestone toward financially sustainable clinical implementation; however, achieving reimbursement is currently a major challenge. As part of a prospective quality-improvement initiative to implement the new code sets, we adopted Agile, a development methodology originally devised in software development. We implemented eight functionally distinct modules (request review, cost estimation, preauthorization, accessioning, prebilling, testing, reporting, and reimbursement consultation) and obtained feedback via an anonymous survey. We managed 50 clinical requests (January to June 2015). The fraction of pursued-to-requested cases (n = 15/50; utilization management fraction, 0.3) aimed for a high rate of preauthorizations. In 13 of 15 patients the insurance plan required preauthorization, which we obtained in 70% and ultimately achieved reimbursement in 50%. Interoperability enabled assessment of 12 different combinations of modules that underline the importance of an adaptive workflow and policy tailoring to achieve higher yields of reimbursement. The survey confirmed a positive attitude toward self-organizing teams. We acknowledge the individuals and their interactions and termed the infrastructure: human pipeline. Nontechnical barriers currently are limiting the scope and availability of clinical genomic sequencing. The presented human pipeline is one approach toward long-term financial sustainability of clinical genomics.
Copyright © 2016 American Society for Investigative Pathology and the Association for Molecular Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27471182      PMCID: PMC5397703          DOI: 10.1016/j.jmoldx.2016.04.003

Source DB:  PubMed          Journal:  J Mol Diagn        ISSN: 1525-1578            Impact factor:   5.568


  24 in total

1.  Physician orders contribute to high-tech imaging slowdown.

Authors:  David C Levin; Vijay M Rao; Laurence Parker
Journal:  Health Aff (Millwood)       Date:  2010 Jan-Feb       Impact factor: 6.301

2.  Including physicians in bundled hospital care payments: time to revisit an old idea?

Authors:  Ateev Mehrotra; Peter Hussey
Journal:  JAMA       Date:  2015-05-19       Impact factor: 56.272

3.  Genetic testing and FDA regulation: overregulation threatens the emergence of genomic medicine.

Authors:  James P Evans; Michael S Watson
Journal:  JAMA       Date:  2015-02-17       Impact factor: 56.272

Review 4.  Diagnostic clinical genome and exome sequencing.

Authors:  Leslie G Biesecker; Robert C Green
Journal:  N Engl J Med       Date:  2014-06-19       Impact factor: 91.245

5.  Health care coverage under the Affordable Care Act--a progress report.

Authors:  David Blumenthal; Sara R Collins
Journal:  N Engl J Med       Date:  2014-07-02       Impact factor: 91.245

Review 6.  Costs and effectiveness of genomic testing in the management of colorectal cancer.

Authors:  Daniel A Goldstein; Walid L Shaib; Christopher R Flowers
Journal:  Oncology (Williston Park)       Date:  2015-03       Impact factor: 2.990

7.  Addressing overutilization in medical imaging.

Authors:  William R Hendee; Gary J Becker; James P Borgstede; Jennifer Bosma; William J Casarella; Beth A Erickson; C Douglas Maynard; James H Thrall; Paul E Wallner
Journal:  Radiology       Date:  2010-08-24       Impact factor: 11.105

8.  Academic health systems management: the rationale behind capitated contracts.

Authors:  P A Taheri; D A Butz; L J Greenfield
Journal:  Ann Surg       Date:  2000-06       Impact factor: 12.969

9.  Good laboratory practices for molecular genetic testing for heritable diseases and conditions.

Authors:  Bin Chen; MariBeth Gagnon; Shahram Shahangian; Nancy L Anderson; Devery A Howerton; Joe D Boone
Journal:  MMWR Recomm Rep       Date:  2009-06-12

Review 10.  Implementation and utilization of genetic testing in personalized medicine.

Authors:  Noura S Abul-Husn; Aniwaa Owusu Obeng; Saskia C Sanderson; Omri Gottesman; Stuart A Scott
Journal:  Pharmgenomics Pers Med       Date:  2014-08-13
View more
  8 in total

1.  Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.

Authors:  Angela Hamblin; Sarah Wordsworth; Jilles M Fermont; Suzanne Page; Kulvinder Kaur; Carme Camps; Pamela Kaisaki; Avinash Gupta; Denis Talbot; Mark Middleton; Shirley Henderson; Anthony Cutts; Dimitrios V Vavoulis; Nick Housby; Ian Tomlinson; Jenny C Taylor; Anna Schuh
Journal:  PLoS Med       Date:  2017-02-14       Impact factor: 11.069

2.  Yield of whole exome sequencing in undiagnosed patients facing insurance coverage barriers to genetic testing.

Authors:  Chloe M Reuter; Jennefer N Kohler; Devon Bonner; Diane Zastrow; Liliana Fernandez; Annika Dries; Shruti Marwaha; Jean Davidson; Elly Brokamp; Matthew Herzog; Joyce Hong; Ellen Macnamara; Jill A Rosenfeld; Kelly Schoch; Rebecca Spillmann; Joseph Loscalzo; Joel Krier; Joan Stoler; David Sweetser; Christina G S Palmer; John A Phillips; Vandana Shashi; David A Adams; Yaping Yang; Euan A Ashley; Paul G Fisher; John J Mulvihill; Jonathan A Bernstein; Matthew T Wheeler
Journal:  J Genet Couns       Date:  2019-09-03       Impact factor: 2.537

3.  Proceedings of the fourth international molecular pathological epidemiology (MPE) meeting.

Authors:  Peter T Campbell; Christine B Ambrosone; Timothy R Rebbeck; Shuji Ogino; Reiko Nishihara; Hugo J W L Aerts; Melissa Bondy; Nilanjan Chatterjee; Montserrat Garcia-Closas; Marios Giannakis; Jeffrey A Golden; Yujing J Heng; N Sertac Kip; Jill Koshiol; X Shirley Liu; Camila M Lopes-Ramos; Lorelei A Mucci; Jonathan A Nowak; Amanda I Phipps; John Quackenbush; Robert E Schoen; Lynette M Sholl; Rulla M Tamimi; Molin Wang; Matty P Weijenberg; Catherine J Wu; Kana Wu; Song Yao; Kun-Hsing Yu; Xuehong Zhang
Journal:  Cancer Causes Control       Date:  2019-05-08       Impact factor: 2.506

Review 4.  The composition and capacity of the clinical genetics workforce in high-income countries: a scoping review.

Authors:  Nick Dragojlovic; Kennedy Borle; Nicola Kopac; Ursula Ellis; Patricia Birch; Shelin Adam; Jan M Friedman; Amy Nisselle; Alison M Elliott; Larry D Lynd
Journal:  Genet Med       Date:  2020-06-24       Impact factor: 8.822

5.  Financing and Reimbursement Models for Personalised Medicine: A Systematic Review to Identify Current Models and Future Options.

Authors:  Rositsa Koleva-Kolarova; James Buchanan; Heleen Vellekoop; Simone Huygens; Matthijs Versteegh; Maureen Rutten-van Mölken; László Szilberhorn; Tamás Zelei; Balázs Nagy; Sarah Wordsworth; Apostolos Tsiachristas
Journal:  Appl Health Econ Health Policy       Date:  2022-04-04       Impact factor: 3.686

6.  Clinically Integrated Molecular Diagnostics in Adenoid Cystic Carcinoma.

Authors:  Julia Thierauf; Nisha Ramamurthy; Vickie Y Jo; Hayley Robinson; Ryan P Frazier; Jonathan Gonzalez; Maciej Pacula; Enrique Dominguez Meneses; Vania Nose; Valentina Nardi; Dora Dias-Santagata; Long P Le; Derrick T Lin; William C Faquin; Lori J Wirth; Jochen Hess; A John Iafrate; Jochen K Lennerz
Journal:  Oncologist       Date:  2019-03-29

7.  Genomic diagnostics within a medically underserved population: efficacy and implications.

Authors:  Kevin A Strauss; Claudia Gonzaga-Jauregui; Karlla W Brigatti; Katie B Williams; Alejandra K King; Cristopher Van Hout; Donna L Robinson; Millie Young; Kavita Praveen; Adam D Heaps; Mindy Kuebler; Aris Baras; Jeffrey G Reid; John D Overton; Frederick E Dewey; Robert N Jinks; Ian Finnegan; Scott J Mellis; Alan R Shuldiner; Erik G Puffenberger
Journal:  Genet Med       Date:  2017-07-20       Impact factor: 8.822

8.  Factors influencing precision medicine knowledge and attitudes.

Authors:  Rohini Chakravarthy; Sarah C Stallings; Michael Williams; Megan Hollister; Mario Davidson; Juan Canedo; Consuelo H Wilkins
Journal:  PLoS One       Date:  2020-11-11       Impact factor: 3.752

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.